Clinical Trial

Convective Radio-frequency Water Vapor Energy Verses Trans-urethral Enucleation of Prostate for Management of Benign Prostatic Hyperplasia

Completed
View on ClinicalTrials.gov →
Summary
Convective RF water vapor energy was introduced as a minimally invasive, radio-frequency thermal energy-based treatment, designed to convectively deliver sterile water vapor, or steam for targeted ablation limited to the transition and central zones in men with clinical BPH. Thus. the aim of the study is to compare Convective RF water vapor energy (Rezum) with trans-urethral enucleation of the prostate (TUEP) regarding efficacy in terms of lower urinary tract symptoms (LUTS) improvement, international prostatic symptoms score (IPSS), improving of the maximum flow rate (Qmax), worsening of erectile and ejaculatory function, and safety regarding post operative complications \& hospital stay.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-08.
Trial Details
NCT Number NCT07587333
Lead Sponsor Beni-Suef University
Conditions BPH (Benign Prostatic Hyperplasia)
Enrollment 70 participants
Start Date 2025-03-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-19